Back to results
US 2020/0138932 A1Published application
Regimens for Immunisation With Meningococcal Conjugates
AssigneeGlaxosmithkline Biologicals SA
InventorLisa DANZIG
Life of this patent
Estimating the term…
Abstract
Multivalent meningococcal conjugate vaccines are administered according to a schedule in which a first dose is administered to a patient aged between 0 and 12 months, and a second dose is administered to the patient aged between 12 and 24 months.
Claims11
1-14. (canceled)
A method for immunizing a patient, comprising:
- (a) administering a multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine to the patient when said patient is aged between 5 and 7 months;
- and (b) administering a multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine to the patient when said patient is aged between 11 and 13 months, wherein the multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine includes capsular saccharide-carrier protein conjugates of meningococcal serogroups A, C, W135, and Y.
A method for immunizing a patient who previously received a multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine when said patient was aged between 5 and 7 months, comprising:
- administering a multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine to the patient when said patient is aged between 11 and 13 months, wherein the multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine includes capsular saccharide-carrier protein conjugates of at least meningococcal serogroups C and Y.
A kit comprising:
- (a) a multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine;
- and (b) instructions for administering the vaccine according to a schedule that includes:
- (a) first administering the vaccine to a patient when said patient is aged between 5 and 7 months;
- and (b) then administering the vaccine to the patient aged between 11 and 13 months, wherein the multivalent meningococcal capsular saccharide-carrier protein conjugate vaccine includes capsular saccharide-carrier protein conjugates of at least meningococcal serogroups C and Y.
1 more element
Dependencies are inferred from the claim text.